<DOC>
	<DOCNO>NCT00001234</DOCNO>
	<brief_summary>Gaucher 's disease lysosomal storage disease result glycocerebroside GLUCOCEREBROSIDE ( 1 ) accumulation macrophage due genetic deficiency enzyme glucocerebrosidase . It may occur patient age . The severe form , Type 2 Gaucher 's Disease occur infant die first year life ( rapidly progressive neurologic deterioration ) . The condition pass generation generation autosomal recessive inheritance . Fabry 's disease isa genetic disorder ( X-linked recessive ) due absence enzyme a-galactosidase A . The disease characterize abnormal collection glycolipids cell ( histiocyte ) within blood vessel wall , tumor thighs , buttock , genitalia ( 2 ) decrease sweating , tingle sensation extremity , cataract . Patients Fabry 's disease die complication kidney , heart , brain . Both condition cause absence specific enzyme ( 3 ) . Patients condition miss ( 3 ) defective gene need normal production enzyme . Studies blood-forming cell bone marrow lead gene therapy use retrovirus vehicle carry insert work gene abnormal diseased cell . This study design measure safety effectiveness transfer work copy gene responsible make miss enzyme cell patient Gaucher 's Fabry disease .</brief_summary>
	<brief_title>Gene Therapy Gaucher 's Fabry Disease Using Viruses Blood-Forming Cells</brief_title>
	<detailed_description>This protocol develop order obtain bone marrow stem cell ex vivo transduction retroviruses contain human glucocerebrosidase gene . We continue enter small number patient protocol year . Studies bone marrow hematopoietic progenitor cell enable u identify effective retroviral construct currently available order carry gene therapy trial patient Gaucher 's disease . The data reveal comparatively simple retroviral construct contain human glucocerebrosidase cDNA drive MoLV promoter highly effective . We obtain approval initiated Phase I safety gene mark investigation patient Type I Gaucher 's Disease .</detailed_description>
	<mesh_term>Gaucher Disease</mesh_term>
	<criteria>Normal patient volunteer . Individuals platelet count less 40,000/ul , PT great 15 second , PTT great 40 second undergo bone marrow aspiration . Individuals hematologic disorder Gaucher Disease , Fabry Disease , mild iron deficiency undergo bone marrow aspiration . HIV positive individual exclude participating .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2002</verification_date>
	<keyword>Bone Marrow</keyword>
	<keyword>Retroviral-Mediated Gene Transfer</keyword>
	<keyword>Hematopoietic Progenitor Cell</keyword>
</DOC>